Health Technology Assessment (HTA) - OHE

Office of Health Economics

Leading intellectual authority on global health economics

News & Insights

Research & Publications
News & Insights
Education
Innovation Policy Prize

Latest Research & Publications

Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Magnification giving a long feel of depth in this large yet seem

Bulletin
June 2022

Innovation, insights and celebration

Gene therapy DNA 3D chemical molecule structure low poly. Polygonal triangle point line healthy cell part. Innovation medicine genome engineering vector illustration future business technology

Insight
June 2022

ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?

Insight
May 2022

Sleepio: Lessons from the Frontier of Digital Therapeutics

patientcare_shutterstock_1190997985_landscape

News
May 2022

Patient Participation Awareness Week 2022

Past Event
Seminar
May 2022

The Value of a QALY Towards the End of Life and its Determinants: Experimental Evidence

News
May 2022

OHE Innovation Policy Prize

Insight
May 2022

Open Source Modelling: From Ideas to Action

Krankenschwestern mit Arzt, Generative KI

Insight
May 2022

Ignoring the needs of our future workforce could have disastrous consequences for the UK NHS and its patients.

Bulletin
May 2022

How can the NHS prepare for future workforce needs?

Choices_Brian-Jackson_AdobeStock_137193688-e1673972063160

Insight
May 2022

Accounting for Preference Heterogeneity in Discrete Choice Experiments

Bulletin
April 2022

Antimicrobial resistance: STEDI Value and Innovation

3D Isometric Flat Vector Conceptual Illustration of Health Equit

Insight
April 2022

Let’s talk about (health) inequalities

News
March 2022

OHE Welcomes Patrick Holmes to the Board of Trustees

Insight
March 2022

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB

Past Event
Masterclass
March 2022

Severity in Value Assessment: From Principle to Practice

Insight
March 2022

NICE’s severity modifier: a step in the right direction, but still a long way to go

News & Insights

Latest Research & Publications

Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

The Future of Global Health Procurement: Issues around Pricing Transparency

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England

Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates

Making Outcome-Based Payment a Reality in the NHS

Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures

Public Preferences for Health Gains and Cures: A Discrete Choice Experiment

All Publications

Filter results by

Innovation, insights and celebration

ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?

Sleepio: Lessons from the Frontier of Digital Therapeutics

Patient Participation Awareness Week 2022

The Value of a QALY Towards the End of Life and its Determinants: Experimental Evidence

OHE Innovation Policy Prize

Open Source Modelling: From Ideas to Action

Ignoring the needs of our future workforce could have disastrous consequences for the UK NHS and its patients.

How can the NHS prepare for future workforce needs?

Accounting for Preference Heterogeneity in Discrete Choice Experiments

Antimicrobial resistance: STEDI Value and Innovation

Let’s talk about (health) inequalities

OHE Welcomes Patrick Holmes to the Board of Trustees

Invest to End TB. Save Lives. World TB Day 2022. Reflections on 60 years of OHE publications on TB

Severity in Value Assessment: From Principle to Practice

NICE’s severity modifier: a step in the right direction, but still a long way to go

Share on Mastodon